Cargando…
Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives
Aggressive inflammatory response leading to hypercoagulability has been found to be associated with disease severity in COVID-19 patients and portends bad treatment outcome. A state of acute disseminated intravascular coagulation (DIC), along with pulmonary embolism and/or deep vein thrombosis, has...
Autores principales: | Sengupta, Tanusree, Majumder, Rinku, Majumder, Samarpan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891480/ https://www.ncbi.nlm.nih.gov/pubmed/33604809 http://dx.doi.org/10.1007/s11010-021-04093-6 |
Ejemplares similares
-
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
por: Chatterjee, Sabyasachi, et al.
Publicado: (2020) -
Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor
por: Sengupta, Tanusree, et al.
Publicado: (2021) -
Soluble Phosphatidylserine Binds to Two Sites on Human Factor IXa in a Ca(2+) Dependent Fashion to Specifically Regulate Structure and Activity
por: Majumder, Rinku, et al.
Publicado: (2014) -
COVID‐19 coagulopathy – what should we treat?
por: Chowdary, Pratima
Publicado: (2022) -
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
por: Hossain, Fokhrul, et al.
Publicado: (2021)